OXYCONTIN

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Japan, Mexico, Netherlands, New Zealand, Poland, Singapore, South Africa, Spain, UK.

Active ingredients

The drug OXYCONTIN contains one active pharmaceutical ingredient (API):

1	Oxycodone UNII C1ENJ2TE6C - OXYCODONE HYDROCHLORIDE
	Oxycodone is a full opioid agonist with no antagonist properties. It has an affinity for kappa, mu and delta opioid receptors in the brain and spinal cord. Oxycodone is similar to morphine in its action. The therapeutic effect is mainly analgesic, anxiolytic, antitussive and sedative.
	Read more about Oxycodone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
OXYCONTIN Film-coated, extended release tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02AA05	Oxycodone	N Nervous system → N02 Analgesics → N02A Opioids → N02AA Natural opium alkaloids
Discover more medicines within N02AA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	12510K, 12518W, 12525F, 12527H, 12538X, 12545G, 8385H, 8386J, 8387K, 8388L, 9399Q, 9400R
BR	Câmara de Regulação do Mercado de Medicamentos	556716100000007, 556716100000107, 556716100000307, 556716100000507
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	25.837-08-04, 25.850-08-04, 25.851-08-04
EE	Ravimiamet	1043165, 1043176, 1043187, 1043198, 1075531, 1075542, 1075553, 1080582, 1080593, 1080605, 1080616, 1080627, 1080638, 1080649, 1080650, 1080661, 1402557, 1402568, 1402579, 1402580, 1402591, 1402603, 1402614, 1402625
ES	Centro de información online de medicamentos de la AEMPS	63446, 63447, 63448, 63449, 68605
FI	Lääkealan turvallisuus- ja kehittämiskeskus	166167, 440389, 516003, 534415, 569650, 586800, 586966, 587113
FR	Base de données publique des médicaments	61200108, 61287223, 62557732, 64681077, 65129174, 66424640, 67467071, 67619878, 68490105
GB	Medicines & Healthcare Products Regulatory Agency	162197, 162199, 162201, 162203, 162205, 186044, 186048, 186050, 186418, 186436, 186448, 186452, 28919, 28967, 28974, 28983, 381583, 381586, 381588, 40752
HK	Department of Health Drug Office	59570, 59571, 59572, 59573, 59574, 66290, 66291, 66292, 66293, 66294, 66295, 66296
HR	Agencija za lijekove i medicinske proizvode	HR-H-118192252, HR-H-188823708
IE	Health Products Regulatory Authority	59124, 59137, 59166, 59182, 59198
JP	医薬品医療機器総合機構	8119002G5020, 8119002G6026, 8119002G7022, 8119002G8029
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	387M97
NL	Z-Index G-Standaard, PRK	57614, 57622, 57630, 57649, 66788, 94277, 94285, 94293, 94307
NZ	Medicines and Medical Devices Safety Authority	15600, 15601, 15602, 15603, 15604, 15605, 15606
PL	Rejestru Produktów Leczniczych	100192812, 100192829, 100192835, 100192841, 100192858
SG	Health Sciences Authority	13076P, 13077P, 13078P, 13080P, 13082P, 14884P, 14885P, 14886P, 14887P, 14888P
US	FDA, National Drug Code	59011-410, 59011-415, 59011-420, 59011-430, 59011-440, 59011-460, 59011-480
ZA	Health Products Regulatory Authority	41/2.9/1098, 41/2.9/1099, 41/2.9/1100, 41/2.9/1101, 41/2.9/1102